基于脂质的纳米粒子介导的组合疗法用于乳腺癌管理:综合性综述
Priya Gupta1, Yub Raj Neupane2, Mohd Aqil1
1Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, India.
Drug delivery and translational research
|June 1, 2023
概括
本综述探讨了用于乳腺癌治疗的基于脂质的新型纳米粒子组合. 这种多模式策略旨在提高疗效和降低毒性,与传统的纳米药物单一治疗相比.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 药物运输 药物运输 药物运输
背景情况:
- 乳腺癌复杂的病因和耐治疗性需要新的治疗策略.
- 目前的纳米医学单一疗法在疗效,毒性和耐药性方面存在局限性.
- 增加的发病率凸显了急需先进乳腺癌治疗方法的迫切需要.
研究的目的:
- 审查基于脂质的纳米粒子介导的乳腺癌组合药物输送方面的进展.
- 探索结合合成,草药,siRNA和单克隆抗体的多模式治疗策略.
- 为开发有效的纳米药物提供见解,具有协同效应和降低毒性.
主要方法:
- 关于乳腺癌联合治疗的当前文献的综述.
- 分析基于脂质的纳米粒子系统,用于治疗剂的联合递送.
- 讨论包括化疗药物,草药剂,siRNA和单克隆抗体在内的组合.
主要成果:
- 组合疗法显示出增强抗瘤疗效和降低毒性的潜力.
- 基于脂质的纳米颗粒为多模式药物输送提供了一个多功能平台.
- 在联合治疗中观察到的协同效应可以克服药物耐药性.
结论:
- 基于脂质的纳米粒子介导的组合疗法是克服乳腺癌治疗挑战的有希望的策略.
- 这种多模式的方法有潜力通过提高疗效和最大限度地减少副作用来显著改善患者的治疗结果.
- 对量身定制的纳米药物进行进一步的研究对于推进乳腺癌治疗至关重要.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
11.0K
09:48Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
405
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K